跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Wesproxen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Wesproxen
Approved
STANDARD
Wesproxen
Lloyd Laboratores, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
692a496a24b8daab
Company
Lloyd Laboratores, Inc.
Type
Standard
Approval Details
Approval Id
692a496a24b8daab
Drug Approval Philippines Name
Wesproxen
Product Name
Wesproxen
Registration Number
DRP-1125
Brand Name
Wesproxen
Generic Name
Naproxen
Dosage Form
Tablet
Dosage Strength
500 mg
Manufacturer
Lloyd Laboratores, Inc.
Trader
Aldril Pharmaceuticals, Inc.
Issuance Date
27 October 2024
Expiry Date
06 January 2030
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID) (Propionic Acid Derivatives)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
692a496a24b8daab
Type
Standard
Back to Philippines FDA Approvals